Citations

Clear

3030 citation(s) found for "Susan, M".

Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, Karoline , McGuffog, Lesley , Barrowdale, Daniel , Lee, Andrew , Soucy, Penny, Ramus, Susan J. , Terry, Mary Beth , Schmutzler, Rita K., Simard, Jacques , Pharoah, Paul D.P., Offit, Kenneth, Chenevix‐Trench, Georgia , Easton, Douglas F. , Antoniou, Antonis C, Nathanson, Katherine L. , Radice, Paolo , Jakubowska, Anna , Lubiński, Jan , Engel, Christoph , Durocher, Francine , Weitzel, Jeffrey N. , Olopade, Olufunmilayo I. , John, Esther M. , Southey, Melissa C. , Eeles, Rosalind A. , Benı́tez, Javier , Ganz, Patricia A. , Gómez, E. , Peterlongo, Paolo , Pensotti, Valeria , Giannini, Giuseppe , Jensen, Uffe Birk , Caligo, Maria A. , Ehrencrona, Hans , Adlard, Julian , Eccles, Diana , Mazoyer, Sylvie , Montagna, Marco , Teo, Soo‐Hwang , Rensburg, Elizabeth J. van , Dı́ez, Orland , Hoya, Miguel de la , Mulligan, Anna Marie , Konstantopoulou, Irene , Vijai, Joseph , Brunet, Joan , Kwong, Ava , James, Paul A. , Claes, Kathleen , Doorn, Helena C. van , Teixeira, Manuel R. , Rennert, Gad , Hulick, Peter J. , Lesueur, Fabienne , Azzollini, Jacopo , Hauke, Jan , Teulé, Àlex , Dennis, Joe , Domchek, Susan M. , Robson, Mark E. , Spurdle, Amanda B. , Mavaddat, Nasim , Neuhausen, Susan L. , Couch, Fergus J. , Antoniou, Antonis C. , Caligo, Maria A , Hulick, Peter J , James, Paul , Lesueur, Fabienne , Peterlongo, Paolo , Ramus, Susan J , Rennert, Gad , Teixeira, Manuel R , Teo, Soo H , van Rensburg, Elizabeth J , Eccles, Diana , de la Hoya, Miguel , Diez, Orland , Radice, Paolo , Weitzel, Jeffrey N , Claes, Kathleen B M , Adlard, Julian , Azzollini, Jacopo , Brunet, Joan , Eeles, Rosalind A , Ehrencrona, Hans , John, Esther M , Joseph, Vijai , Konstantopoulou, Irene , Olopade, Olufunmilayo I , Southey, Melissa C , Jakubowska, Anna , Nathanson, Katherine L , Barrowdale, Daniel , Benitez, Javier , Engel, Christoph , Montagna, Marco , Simard, Jacques , Chenevix-Trench, Georgia , Gómez-García, Encarna B , Hauke, Jan , Lubinski, Jan , Terry, Mary Beth , Kwong, Ava

Mayo Clinic

JNCI: Journal of the National Cancer Institute | November 29, 2016 | Volume: 109 | Issue: 7 | Pages: No page available

10.1093/jnci/djw302 | PMID 28376175 Get It

Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Hamdi, Yosr , Collaborators, NBCS, Soucy, Penny, Adoue, Véronique , Michailidou, Kyriaki , Canisius, Sander , Lemaçon, Audrey , Droit, Arnaud , Andrulis, Irene L. , Baynes, Caroline, Blomqvist, Carl , Bogdanova, Natalia , Bojesen, Stig E. , Bolla, Manjeet K. , Børresen‐Dale, Anne‐Lise , Brand, Judith S. , Brauch, Hiltrud , Brenner, Hermann , Burwinkel, Barbara , Chang‐Claude, Jenny , Darabi, Hatef, Devilee, Peter , Dörk, Thilo , Eriksson, Mikael , Fasching, Peter A. , Figueroa, Jonine D. , Flyger, Henrik, García‐Closas, Montserrat , Goldberg, Mark S. , González‐Neira, Anna , Grenaker-Alnæs, Grethe Irene, Guénel, Pascal , Haeberle, Lothar, Haiman, Christopher A., Hamann, Ute, Hallberg, Emily, Hooning, Maartje J. , Jakubowska, Anna , Jones, Michael E. , Kabisch, Maria, Kataja, Vesa , Lambrechts, Diether , Lindblom, Annika , Lubiński, Jan , Mannermaa, Arto, Maranian, Mel, Margolin, Sara , Marme, Frederik, Neven, Patrick , Olswold, Curtis, Peto, Julian, Plaseska‐Karanfilska, Dijana , Pylkäs, Katri , Radice, Paolo , Sawyer, Elinor J. , Schmidt, Marjanka K. , Shu, Xiao-Ou , Southey, Melissa C. , Swerdlow, Anthony J. , Tollenaar, Rob A.�E.�M. , Tomlinson, Ian , Torres, Diana , Truong, Thérèse , Vachon, Celine M. , Ouweland, Ans M.W. van den, Wang, Qin , Winqvist, Robert , Investigators, kConFab AOCS, Benı́tez, Javier , Chenevix‐Trench, Georgia , Dunning, Alison M. , Kristensen, Vessela N. , Easton, Douglas F. , Pastinen, Tomi , Simard, Jacques , Durocher, Francine , Zheng, Wei , Thorne, Heather , Lambrechts, Diether , Vachon, Celine, Collaborators, NBCS, Anton‐Culver, Hoda , Arndt, Volker , Bonanni, Bernardo , Broeks, Annegien , Couch, Fergus J. , Cox, Angela , Cross, Simon S. , Czene, Kamila , Dennis, Joe , dos‐Santos‐Silva, Isabel , Eriksson, Mikael , Giles, Graham G. , Hooning, Maartje J. , Hopper, John L. , Marchand, Loı̈c Le , Mannermaa, Arto , Milne, Roger L. , Neuhausen, Susan L. , Nevanlinna, Heli , Rudolph, Anja , Vachon, Celine M. , Zheng, Wei , Pharoah, Paul D.P. , Hall, Per N , Nord, Silje , Dörk, Thilo , Lambrechts, Diether , Swerdlow, Anthony J , Radice, Paolo , Southey, Melissa C , Dunning, Alison M , Jakubowska, Anna , Jones, Michael E , Lambrechts, Diether , Brenner, Hermann , Guénel, Pascal , Torres, Diana , García-Closas, Montserrat , Schmidt, Marjanka K , Michailidou, Kyriaki , Bogdanova, Natalia V , Benitez, Javier , Simard, Jacques , Chenevix-Trench, Georgia , Zheng, Wei , Figueroa, Jonine D , Pylkäs, Katri , Devilee, Peter , Lubinski, Jan , Bojesen, Stig E , Truong, Therese , Brauch, Hiltrud , Lindblom, Annika , Plaseska-Karanfilska, Dijana , Sawyer, Elinor J , Droit, Arnaud

Mayo Clinic

Oncotarget | November 28, 2016 | Volume: 7 | Issue: 49 | Pages: 80140-80163

10.18632/oncotarget.12818 | PMID 27792995 Get It

PTU-133 Effect of Eluxadoline on Abdominal and Bowel Symptoms Over Time in Phase 3 Clinical Trials in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)
Harris, LA, Lucak, Susan, Dove, LS, Covington, PS, Chang, Lin

Mayo Clinic

BSG 2016 | November 23, 2016 | Volume: No volume available | Issue: No issue available | Pages: A122.2-A123

10.1136/gutjnl-2016-312388.219 Get It

Data and Safety Monitoring Board Evaluation and Management of a Renal Adverse Event Signal in TOPCAT
Assmann, Susan F., Linas, Stuart L., Rice, Madeline Murguia , Singh, Steven , Boineau, Robin , McKinlay, Sonja M., Greenberg, Barry , Bristow, Michael R. , Sharma, Kavita , Gersh, Bernard J. , Grady, Christine

Mayo Clinic

European Journal of Heart Failure | November 21, 2016 | Volume: 19 | Issue: 4 | Pages: 457-465

10.1002/ejhf.686 | PMID 27873428 Get It

Abstract Clinical trial Data and Safety Monitoring Boards (DSMBs) have a primary obligation of ensuring study participant safety, while maintaining trial integrity. The role of DSMBs is expanding, and ideally should include post-hoc reporting of deliberative processes related to clinically important safety issues or factors that could impact on future trial designs. We describe how the TOPCAT DSMB detected, investigated, and adjudicated an unexpectedly large renal adverse event signal midway through the trial, and offer general guidelines for dealing with similar unanticipated occurrences in future trials. The detection of a greater than expected incidence of deterioration in renal function, occurring in 6.1% of patients in the spironolactone arm compared with 3.9% in the placebo arm (P = 0.009), led to an in-depth DSMB review of associated study medication withdrawals and adverse events. The trial continued uninterrupted throughout the review, which reached the conclusions that spironolactone-associated renal dysfunction did not compromise overall patient safety or interfere with a perceived efficacy signal. Although no discrete mechanism for the spironolactone-associated renal adverse event signal was identified, likely possibilities are discussed. In clinical trials, DSMBs and co-ordinating centres should have the resources to detect, investigate, and adjudicate unexpected safety issues, with goals of ensuring patient safety and preserving the potential for detection of therapeutic effectiveness. In TOPCAT, spironolactone-associated renal dysfunction emerged as a potentially trial-threatening adverse event and, although clinically important, did not lead to compromise of patient safety, trial interruption, termination, or apparent loss of treatment effectiveness.
Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast
Bodelón, Clara , Oh, Hannah , Chatterjee, Nilanjan , García‐Closas, Montserrat , Palakal, Maya, Sherman, Mark E. , Geller, Berta M., Vacek, Pamela M. , Weaver, Donald L. , Chicoine, Rachael E., Papathomas, Daphne, Xiang, Jackie , Patel, Deesha A. , Khodr, Zeina G. , Linville, Laura , Clare, Susan E. , Visscher, Daniel W., Mies, Carolyn, Hewitt, Stephen M. , Brinton, Louise A. , Storniolo, Anna Maria , He, Chunyan , Figueroa, Jonine D. , Pfeiffer, Ruth M. , Chanock, Stephen Jacob , Gierach, Gretchen L. , García-Closas, Montserrat , Figueroa, Jonine D

Mayo Clinic

International Journal of Cancer | November 10, 2016 | Volume: 140 | Issue: 4 | Pages: 825-832

10.1002/ijc.30512 | PMID 27859137 Get It

Terminal duct lobular units (TDLUs) are the predominant source of future breast cancers, and lack of TDLU involution (higher TDLU counts, higher acini count per TDLU and the product of the two) is a breast cancer risk factor. Numerous breast cancer susceptibility single nucleotide polymorphisms (SNPs) have been identified, but whether they are associated with TDLU involution is unknown. In a pooled analysis of 872 women from two studies, we investigated 62 established breast cancer SNPs and relationships with TDLU involution. Poisson regression models with robust variance were used to calculate adjusted per‐allele relative risks (with the non‐breast cancer risk allele as the referent) and 95% confidence intervals between TDLU measures and each SNP. All statistical tests were two‐sided; P < 0.05 was considered statistically significant. Overall, 36 SNPs (58.1%) were related to higher TDLU counts although this was not statistically significant (p = 0.25). Six of the 62 SNPs (9.7%) were nominally associated with at least one TDLU measure: rs616488 (PEX14), rs11242675 (FOXQ1) and rs6001930 (MKL1) were associated with higher TDLU count (p = 0.047, 0.045 and 0.031, respectively); rs1353747 (PDE4D) and rs6472903 (8q21.11) were associated with higher acini count per TDLU (p = 0.007 and 0.027, respectively); and rs1353747 (PDE4D) and rs204247 (RANBP9) were associated with the product of TDLU and acini counts (p = 0.024 and 0.017, respectively). Our findings suggest breast cancer SNPs may not strongly influence TDLU involution. Agnostic genome‐wide association studies of TDLU involution may provide new insights on its biologic underpinnings and breast cancer susceptibility.
Alcohol Consumption and the Risk of Colorectal Cancer for Mismatch Repair Gene Mutation Carriers
Dashti, S. Ghazaleh , Buchanan, Daniel D. , Jayasekara, Harindra , Ouakrim, Driss Ait , Rosty, Christophe , Winship, Ingrid , Parry, Susan, Haile, Robert W. , Gallinger, Steven , Thibodeau, Stephen N. , Lindor, Noralane M. , Jenkins, Mark A. , Win, Aung Ko , Clendenning, Mark , Macrae, Finlay , Giles, Graham G. , Casey, Graham , Marchand, Loı̈c Le , Newcomb, Polly A. , Potter, John D. , Baron, John A. , Hopper, John L. , Buchanan, Daniel D , Win, Aung K , Jenkins, Mark A , Haile, Robert W , Rosty, Christophe , Winship, Ingrid M , Jayasekara, Harindra

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | November 4, 2016 | Volume: 26 | Issue: 3 | Pages: 366-375

10.1158/1055-9965.epi-16-0496 | PMID 27811119 Get It

Abstract Background: People with germline mutation in one of the DNA mismatch repair (MMR) genes have increased colorectal cancer risk. For these high-risk people, study findings of the relationship between alcohol consumption and colorectal cancer risk have been inconclusive. Methods: 1,925 MMR gene mutations carriers recruited into the Colon Cancer Family Registry who had completed a questionnaire on lifestyle factors were included. Weighted Cox proportional hazard regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between alcohol consumption and colorectal cancer. Results: Colorectal cancer was diagnosed in 769 carriers (40%) at a mean (SD) age of 42.6 (10.3) years. Compared with abstention, ethanol consumption from any alcoholic beverage up to 14 g/day and &gt;28 g/day was associated with increased colorectal cancer risk (HR, 1.50; 95% CI, 1.09–2.07 and 1.69; 95% CI, 1.07–2.65, respectively; Ptrend = 0.05), and colon cancer risk (HR, 1.78; 95% CI, 1.27–2.49 and 1.94; 95% CI, 1.19–3.18, respectively; Ptrend = 0.02). However, there was no clear evidence for an association with rectal cancer risk. Also, there was no evidence for associations between consumption of individual alcoholic beverage types (beer, wine, spirits) and colorectal, colon, or rectal cancer risk. Conclusions: Our data suggest that alcohol consumption, particularly more than 28 g/day of ethanol (∼2 standard drinks of alcohol in the United States), is associated with increased colorectal cancer risk for MMR gene mutation carriers. Impact: Although these data suggested that alcohol consumption in MMR carriers was associated with increased colorectal cancer risk, there was no evidence of a dose-response, and not all types of alcohol consumption were associated with increased risk. Cancer Epidemiol Biomarkers Prev; 26(3); 366–75. ©2016 AACR.
Regarding the Safety of Interventional Pain Procedures in the Setting of Anticoagulation
Moeschler, Susan M. , Eldrige, Jason S. , Warner, Nafisseh S.

Mayo Clinic

Pain Medicine | October 27, 2016 | Volume: 18 | Issue: 4 | Pages: 819-820

10.1093/pm/pnw253 | PMID 28034976 Get It

Willingness to Be a Brain Donor
Boise, Linda, Hinton, Ladson , Rosen, Howard J. , Ruhl, Mary C., Albert, Marilyn , Denny, Andrea, Hughes, Travonia, Lingler, Jennifer H. , Morhardt, Darby, Parfitt, Francine, Peterson-Hazan, Susan, Pop, Viorela, Rose, Tara , Shah, Raj C. , Hinton, Ladson , Dodge, Hiroko Hayama , Mattek, Nora , Grill, Joshua D. , Shah, Raj C

Mayo Clinic

Alzheimer Disease & Associated Disorders | October 25, 2016 | Volume: 31 | Issue: 2 | Pages: 135-140

10.1097/wad.0000000000000174 | PMID 27779492 Get It

Introduction: Racial and ethnic groups are under-represented among research subjects who assent to brain donation in Alzheimer disease research studies. There has been little research on this important topic. Although there are some studies that have investigated the barriers to brain donation among African American study volunteers, there is no known research on the factors that influence whether or not Asians or Latinos are willing to donate their brains for research. Methods: African American, Caucasian, Asian, and Latino research volunteers were surveyed at 15 Alzheimer Disease Centers to identify predictors of willingness to assent to brain donation. Results: Positive predictors included older age, Latino ethnicity, understanding of how the brain is used by researchers, and understanding of what participants need to do to ensure that their brain will be donated. Negative predictors included African/African American race, belief that the body should remain whole at burial, and concern that researchers might not be respectful of the body during autopsy. Discussion: The predictive factors identified in this study may be useful for researchers seeking to increase participation of diverse ethnic groups in brain donation.